1. Home
  2. HALO vs BILI Comparison

HALO vs BILI Comparison

Compare HALO & BILI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • BILI
  • Stock Information
  • Founded
  • HALO 1998
  • BILI 2009
  • Country
  • HALO United States
  • BILI China
  • Employees
  • HALO N/A
  • BILI N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • BILI EDP Services
  • Sector
  • HALO Health Care
  • BILI Technology
  • Exchange
  • HALO Nasdaq
  • BILI Nasdaq
  • Market Cap
  • HALO 7.4B
  • BILI 8.8B
  • IPO Year
  • HALO N/A
  • BILI 2018
  • Fundamental
  • Price
  • HALO $59.97
  • BILI $22.82
  • Analyst Decision
  • HALO Buy
  • BILI Buy
  • Analyst Count
  • HALO 8
  • BILI 8
  • Target Price
  • HALO $65.63
  • BILI $23.25
  • AVG Volume (30 Days)
  • HALO 1.3M
  • BILI 3.0M
  • Earning Date
  • HALO 08-05-2025
  • BILI 08-21-2025
  • Dividend Yield
  • HALO N/A
  • BILI N/A
  • EPS Growth
  • HALO 55.40
  • BILI N/A
  • EPS
  • HALO 3.76
  • BILI N/A
  • Revenue
  • HALO $1,084,306,000.00
  • BILI $3,882,060,637.00
  • Revenue This Year
  • HALO $25.48
  • BILI $15.65
  • Revenue Next Year
  • HALO $19.78
  • BILI $8.71
  • P/E Ratio
  • HALO $15.95
  • BILI N/A
  • Revenue Growth
  • HALO 25.64
  • BILI 21.83
  • 52 Week Low
  • HALO $42.01
  • BILI $12.72
  • 52 Week High
  • HALO $70.51
  • BILI $31.77
  • Technical
  • Relative Strength Index (RSI)
  • HALO 64.61
  • BILI 51.99
  • Support Level
  • HALO $57.68
  • BILI $22.02
  • Resistance Level
  • HALO $59.38
  • BILI $25.38
  • Average True Range (ATR)
  • HALO 1.32
  • BILI 0.61
  • MACD
  • HALO 0.26
  • BILI -0.31
  • Stochastic Oscillator
  • HALO 70.87
  • BILI 25.89

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About BILI Bilibili Inc.

Bilibili is a Chinese online entertainment platform best known for its YouTube-like video-sharing site. Founded in 2009, it initially focused on long-form content centered around anime, comics, and gaming, catering primarily to Gen Z users. Over time, the platform has broadened its content offerings to include a wider range of interests, successfully attracting a more diverse audience beyond the Gen Z demographic.

Share on Social Networks: